The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 regarding its interests in Spire Healthcare Group plc. According to the disclosure, Vanguard holds 14,417,149 of the 1p ordinary shares, which equates to 3.58% of the relevant securities in Spire Healthcare. This disclosure is in accordance with Rule 8.3 of the Takeover Code, which pertains to a person with interests representing 1% or more in relevant securities.

The disclosure also provided details of recent dealings by Vanguard, which included the sale of 2,499 ordinary shares at a price of 2.47 GBP per unit on October 22, 2026. No further stock-settled derivative positions or other securities dealings were reported in this disclosure.

Both indemnity agreements and any arrangements related to options or derivatives have been stated as non-existent in this filing. The contact for this disclosure is Shawn Acker, and the position was disclosed on October 23, 2026.